ArticlePloS one2013

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.

Lawrence S Lamb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.